Publication:
Hyponatraemia, mortality and haemodialysis: An unexplained association.

dc.contributor.authorPérez-García, Rafael
dc.contributor.authorPalomares, Inés
dc.contributor.authorMerello, José Ignacio
dc.contributor.authorRamos, Rosa
dc.contributor.authorMaduell, Francisco
dc.contributor.authorMolina, Manolo
dc.contributor.authorAljama, Pedro
dc.contributor.authorMarcelli, Daniele
dc.contributor.authorORD Group
dc.date.accessioned2023-01-25T08:30:23Z
dc.date.available2023-01-25T08:30:23Z
dc.date.issued2015-12-03
dc.description.abstractAs in the general population, in patients on haemodialysis (HD) hyponatraemia is associated with higher mortality risk. The objective of this article was to study the relationship between predialysis serum sodium (sNa) and mortality in an HD population. We also intended to define hyponatraemia and determine the characteristics of hyponatraemic patients in terms of anthropometric data, analytical features, dialysis measurements and hydration (bioimpedance). Observational, descriptive study of a cohort of HD incident patients. The independent variable was the mean of each patient's sNa analysed during their first 6 months on HD. A total of 4,153 patients were included in the study. Mean age was 64.7 years; 65.2% of the patients were male and 35% were diabetics. Mean follow-up time was 21.48 (SD) (1.31) months. sNa had a normal distribution, with a mean (SD)=138.46 (2.7) mEq/l. Body weight, diabetes mellitus, systolic blood pressure, interdialytic weight gain, total ultrafiltration, serum glucose, albumin and creatinine, vascular access and haemodialysis type, acquire significant differences between sodium quartiles. Lean tissue index (LTI) in patients with low serum sodium, Q1 (135 mEq/l), was significantly lower than the LTI of patients from the other serum sodium quartiles. Patients with sNa HD patients with hyponatraemia patients have a poor prognosis and present malnutrition or fluid overload.
dc.identifier.doi10.1016/j.nefro.2015.10.005
dc.identifier.essn1989-2284
dc.identifier.pmid26656402
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.nefro.2015.10.005
dc.identifier.urihttp://hdl.handle.net/10668/9659
dc.issue.number1
dc.journal.titleNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
dc.journal.titleabbreviationNefrologia
dc.language.isoen
dc.language.isoes
dc.organizationHospital Universitario Reina Sofía
dc.page.number42-50
dc.pubmedtypeJournal Article
dc.pubmedtypeObservational Study
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectDiabetes
dc.subjectHaemodialysis
dc.subjectHemodiálisis
dc.subjectHiponatremia
dc.subjectHyponatraemia
dc.subjectMortalidad
dc.subjectMortality
dc.subjectNatremia
dc.subjectSerum sodium
dc.subject.meshAged
dc.subject.meshCohort Studies
dc.subject.meshCreatinine
dc.subject.meshDiabetes Mellitus
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHyponatremia
dc.subject.meshKidney Failure, Chronic
dc.subject.meshMale
dc.subject.meshPrognosis
dc.subject.meshRenal Dialysis
dc.subject.meshSodium
dc.titleHyponatraemia, mortality and haemodialysis: An unexplained association.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number36
dspace.entity.typePublication

Files